US FDA approves Bristol Myers' schizophrenia drug-March 2024-www.financetom.com

US FDA approves Bristol Myers' schizophrenia drug

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA approves Bristol Myers' schizophrenia drug

Oct 2, 2024 11:50 PM

(Corrects paragraph 1 to say U.S. FDA is news source, not

Bristol Myers)

Sept 26 (Reuters) - The U.S. FDA approved Bristol Myers

Squibb's ( BMY ) schizophrenia drug on Thursday, providing

patients with a treatment option that reduces symptoms of the

mental disorder without common side effects, the health

regulator said.

Previous page： Explained: Joe Biden's Made in America Tax Plan Next page： Archegos Capital blow up and the never-ending crisis at Credit Suisse

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Explained: Joe Biden's Made in America Tax Plan

Apr 9, 2021

In a speech a few days ago, the US President said that his plan was fairer to the country's middle class.

Archegos Capital blow up and the never-ending crisis at Credit Suisse

Apr 7, 2021

On April 6, Credit Suisse announced the departure of chief risk and compliance officer Lara Warner and head of the investment banking division Brian Chin.

‘System of Espionage’: Prosecutor charges French arm of Ikea with snooping

Apr 8, 2021

A report in the New York Times states that the French arm of the company also stands accused of hiring a former military operative for more ‘clandestine operations’.

US auto industry calls for government help as it warns of impact of chip shortage

Apr 6, 2021

US President Joe Biden in February ordered several Federal agency actions to address the chip crisis and is also seeking USD 37 billion in funding for legislation to supercharge chip manufacturing in the United States.